[Lupus nephritis: treatments for today and tomorrow]

Nefrologia. 2001;21(6):522-3.
[Article in Spanish]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Animals
  • Antibodies, Monoclonal / therapeutic use
  • Bone Marrow Transplantation
  • CD40 Ligand / immunology
  • Cladribine / therapeutic use
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Forecasting
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / therapeutic use
  • Lupus Nephritis / drug therapy
  • Lupus Nephritis / therapy*
  • Mycophenolic Acid / analogs & derivatives*
  • Mycophenolic Acid / therapeutic use
  • Oligonucleotides / therapeutic use
  • Plasmapheresis
  • Vidarabine / administration & dosage
  • Vidarabine / analogs & derivatives
  • Vidarabine / therapeutic use

Substances

  • Adrenal Cortex Hormones
  • Antibodies, Monoclonal
  • Immunosuppressive Agents
  • Oligonucleotides
  • CD40 Ligand
  • Cladribine
  • Vidarabine
  • Mycophenolic Acid
  • fludarabine
  • abetimus